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Introduction
Endometrial ablation (EA), which is performed by resec-
toscopy, use of a thermal balloon, cryotherapy, micro-
wave energy, radiofrequency electrosurgery or exposure
to circulated heated liquid, is a highly effective treatment
for menorrhagia [1].
Although the short-term success rate is encouraging,
the long-term results after EA have yet to be determined.
Therefore, careful monitoring of the patient is essential.
In particular, intrauterine adhesions and contractures
that develop after EA may allow for more aggressive
placental invasion or adherence, and make future
pregnancy evaluation and management difficult.
Pregnancy after EA is rare, and has a high rate of
complications [2–45], including maternal death [46].
Because the true effects of EA on pregnancy outcomes
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SUMMARY
Objective: Treating menorrhagia in women of reproductive age by endometrial ablation (EA) decreases menstrual
flow and increases quality of life. However, unexpected pregnancy and associated complications are challenges
following EA.
Materials and Methods: From January 2000 to March 2008, a total of 356 women aged 26–45 years with persist-
ent menorrhagia underwent total hysteroresectoscopic EA with follow-up at our hospital and were retrospectively
evaluated. We also performed a literature search for articles reporting pregnancy after EA published between
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ectopic, two cornual and two cervical ectopic pregnancies were reported. The ectopic pregnancy rate was 6.5%
(8/123). There were nine perinatal deaths, corresponding to a perinatal mortality rate of 14% (9/64). Five babies
had congenital anomalies, including craniosynostosis (1 case), a set of twins with Down syndrome (1 case),
agenesis of the corpus callosum (1 case), bilateral talipes (1 case), and one case of fetal malformation caused
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remain unknown, each pregnancy should be reported.
Herein we report five pregnancies that occurred after EA
among 356 cases treated at our institute, and we re-
viewed the literature to evaluate pregnancy outcomes
and complications.
Materials and Methods
From January 2000 to March 2008, a total of 356
women, aged 26–45 years old with persistent menorrha-
gia, underwent total hysteroresectoscopic endometrial
resection and were included in this study. Endometrial
suppression was not used before the procedures. All
procedures were conducted through a hysteroscopic
resectoscope while the patient was under spinal anes-
thesia or general anesthesia. The distention fluid was 5%
dextrose and was infused using a gravity-feed infusion
system. During the surgery, the endometrium (3 mm)
was resected and coagulated using a 3-mm rollerball
electrode. The operation started with resection of long
strips of the endometrium (depth < 3 mm) from the
fundus to the low segment using a cutting loop. The rest
of endometrium was then coagulated using the roller-
ball electrode. The generator power was set at 90 W
for cutting and 60 W for coagulation.
For women in whom uterine polyps or myomas were
found, concomitant resections were done. Submuco-
sal myoma resections were carried out using unipolar
cutting-loop resection techniques. All of the resected
endometrial strips, myomatous fragments and polyps
were sent for histological evaluation. During EA the
surgeon ensured that no endometrial tissue was left 
in situ.
All procedures were completed safely; however, two
women sustained uterine perforation and underwent
hysterectomies. In a third woman, the procedure was
abandoned because of suspected endometrial malig-
nancy. None of the patients showed any signs or symp-
toms of fluid overload or hyponatremia. All patients
were monitored for postoperative morbidity at 1 week
and 1 month after surgery, then every 6 months by tele-
phone, mail or at our clinics.
Patient satisfaction was assessed with the question
“How satisfied or dissatisfied are you with the result of
surgery related to menstrual flow and dysmenorrhea?”
Patients rated their overall satisfaction on a 4-point
scale (1 = very satisfied, 2 = satisfied, 3 = dissatisfied, 4 =
very dissatisfied). The need for repeat surgery or hys-
terectomy was also reported.
We performed a literature search in MEDLINE 
with a date range from January 1, 1983 to August 30,
2008, using the keywords “pregnancy”, “endometrial
ablation”, and “hysteroscopy”, to identity potentially
eligible case reports and cross-referenced articles.
Results
A total of 334 women (94%) were eligible for follow-
up after surgery. The follow-up duration ranged from
7 months to 109 months (mean=48.7 months). Twenty-
two women were lost to follow up. Among the 334
women who were successfully followed-up after EA,
161 (48%) had normal flow, 33 (10%) had hypomen-
orrhea, 31 (9%) had heavy flow, and 82 (25%) contin-
ued to have amenorrhea. Seventeen (5%) women were
unsatisfied with the results and seven received hys-
terectomies because of EA failure. Ten women (3%)
underwent EA again.
During the follow-up period, five pregnancies oc-
curred after the procedure, and the mean age of these
women was 36 years (range, 34–40 years). The out-
comes of the five pregnancies are shown in Tables 1
and 2 [2–46]. Of the five patients who conceived after
surgery, two patients had normal flow and three patients
had hypomenorrhea. Two pregnancies resulted in spon-
taneous miscarriages that were managed by suction cu-
rettage. One pregnancy was terminated at the mother’s
request by oral mifipristone. The other two illustrated
cases are described in more detail below.
Case 1
A 34-year-old woman at 12 weeks gestation opted 
to terminate her pregnancy. At age of 32, she under-
went hysteroscopic EA at our hospital. After EA the
patient experienced light menses. Surgical termination
of the pregnancy at a local gynecology clinic failed
because of severe fibrosis involving the lower uterine
cavity, which rendered sounding and dilation impossi-
ble. The patient was then transferred to our hospital
where hysterotomy and bilateral tubal sterilization
were performed. A fetus at 12 weeks of gestation was
found in the left horn of the uterus, and the obliter-
ated lower uterine cavity was found during operation.
After the operation, she continued to experience a light
period.
Case 2
A 36-year-old woman, gravida 3, para 2, presented at
our emergency room at 22 weeks of gestation with
preterm premature rupture of membranes. She had two
prior full term vaginal deliveries without complica-
tions. Eight months before the current pregnancy, she
had undergone hysteroscopic endometrial resection for
menorrhagia and dysmenorrhea.
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After the surgery the patient had been hypomenor-
rheic, but with persistent dysmenorrhea. Upon admission
she underwent tocolysis for 48 hours, and was treated
with ampicillin for 7 days. There were no labor pains,
but continued leakage of amniotic fluid was noted. The
patient declined to terminate the pregnancy after de-
tailed discussion regarding infection, prematurity, and
other potential complications of pregnancy. She rested
in the hospital for the next 10 weeks. During this time
there was persistent loss of amniotic fluid with oligo-
hydramnios. At 33 weeks, she developed a fever, fundal
tenderness, and clinical suspicion of chorioamnionitis.
A cesarean section delivery was performed, and a
2,060 g female baby with Apgar scores of 1 and 3 was
delivered. During the cesarean section, the placenta
failed to separate. A diagnosis of placenta increta was
made and a supra-cervical hysterectomy was performed.
The postoperative course was uneventful. The patho-
logic examination of the uterus and placenta showed
placenta increta. Unfortunately, the baby died after 
3 days because of pulmonary hypoplasia.
Literature review
Overall, 123 pregnancies after EA have been reported
in the English literature [2–46], including the five preg-
nancies reported in this paper. The outcomes are pre-
sented in Tables 1 and 2. This literature review revealed
that the mean age at surgery was 36 years (range,
25–46 years) and the time between surgery and con-
ception ranged from 3 months [13] to 12 years [38],
with a mean duration of 25 months. The recorded men-
strual pattern at the time of pregnancy in 47 of the
123 women showed hypomenorrhea in 27 cases (56%),
amenorrhea in 10 (21%), eumenorrhea in nine (19%),
and menorrhagia in one (2%).
Of the 123 pregnancies after EA, a total of 83
(67%) were terminated before 20 weeks. Fifty-nine
(48%) of the pregnancies were successfully terminated
at the mother’s request. The remaining 64 pregnancies
were associated with multiple complications including
spontaneous abortion (27%, 17/64), premature rupture
of membranes (16%, 10/64), premature birth (30%,
19/64), cesarean sections (42%, 27/64) and placental
adherent complications (25%, 15/64). Of the 17 women
with placental adherent complications, cesarean hys-
terectomy was necessary in eight patients [6,12,23,
42,43,45,46] including two of our cases. Four tubal
ectopic pregnancies [5,20,22], two cornual ectopic
pregnancies [22] and two cervical ectopic pregnancies
[22,23] were reported, yielding an ectopic pregnancy
rate of 7% (8/120). Both cornual ectopic pregnancies
underwent subtotal hysterectomy [22]. Of the two
cervical pregnancies, one underwent cervical curettage
with a Foley’s balloon tamponade [22], while the other
was treated with two doses of intramuscular methotrex-
ate [23]. There were eight perinatal deaths including
four intrauterine deaths and four neonatal deaths. 
The perinatal mortality rate was 13%. The only mater-
nal death was a 29-year-old woman who died 5 years
after EA. At 24 weeks of gestation, she experienced
sudden rupture of unscarred uterus and massive intra-
abdominal bleeding, and died because of hemorrhagic
shock [46].
There were five babies with congenital anomalies out
of 36 pregnancies that progressed beyond 20 weeks of
gestation, including a 2,520 g baby with craniosynosto-
sis and hearing loss born to a 44-year-old woman [6],
a set of twins with Down syndrome born at 35 weeks
of gestation to a 40-year-old woman [39], an intrauter-
ine death at 20 weeks with bilateral talipes [40], one
case of agenesis of the corpus callosum [41], and an
amniotic band deformity in a neonatal 796 g baby, who
was born at 26 weeks of gestation [42]. There were four
intrauterine deaths that occurred at 20, 28, 31, and 
36 weeks respectively, including the above mentioned
fetus with bilateral talipes [9,28,32,40].
There were four neonatal deaths, two with severe
prematurity (1,154 g and 375 g) [26,30], one with pre-
maturity (796 g) and amniotic band syndrome (as men-
tioned above) [42], and one (2,060 g) with pulmonary
hypoplasia (case 2 in the present study). Of the 36
pregnancies after EA that continued beyond 20 weeks,
only 28 (78%) resulted in surviving infants.
Four women became pregnant twice after EA. One
woman aborted both of her pregnancies (at 7 and 6
weeks of gestation) [12]; the other three women each
had one spontaneous abortion and one term live birth
[13,17,32].
Discussion
In 1991, a case of pregnancy after EA was reported
while the first maternal death reported in 2008 [46]
and the serious adverse events summarized here illus-
trate the risk of pregnancies after EA. The pregnancy
rate after EA is 0.24–0.68% [17,18,36], and was 1.4%
in our series, representing a new clinical entity with diag-
nostic and management challenges. As in Asherman’s
syndrome, significant intrauterine adhesions and con-
tractures may allow for aggressive placental invasion or
adherence. Poor obstetric outcomes have been reported
for Asherman’s syndrome and for pregnancy after EA
[17,47], while half of the pregnancies after EA sum-
marized in this literature review were terminated at the
mother’s request.
There is still limited information on the uterine as-
sessment of women who become pregnant after EA.
However, a positive correlation between normality of the
uterine cavity and the subsequent outcome of the preg-
nancy has been reported [17]. Hysteroscopy is the gold-
standard diagnostic method for intrauterine adhesions;
however, routine use of hysteroscopy for all women of
reproductive age after EA is not advised. Hysterosalp-
ingography is a relatively inexpensive office procedure.
It is the best diagnostic test for evaluating the fallopian
tubes. It also provides detailed information about the
uterine cavity contour, and the region of the internal os.
Currently, the two most useful classification systems for
intrauterine scarring in Asherman’s syndrome are the
European Society Hysteroscopy system [48] and the
American Society for Reproductive Medicine scoring
system [49]. However, neither system can completely
predict outcomes. Transvaginal ultrasound plus saline
sonohysterography performed during the periovulatory
phase is the best approach to evaluate the uterine cavity
contours.
In hypomenorrheic and amenorrheic women, who
represent about 78% of the reported post-EA pregnan-
cies, pregnancy must be confirmed by reviewing the case
history, ultrasound and serum β-HCG measurement to
confirm viable intrauterine pregnancy and to assess ges-
tational age. During pregnancy, serial ultrasound scans
should be performed to check fetal growth and abnor-
mal placentation. In women who choose to terminate
a pregnancy, preoperative counseling and ultrasound
examination are necessary. They should also be coun-
seled about the possibility of failed curettage due to
severe adhesion of the cavity, and the need for a hys-
terotomy or possibly a hysterectomy. There are some
reports regarding medical abortions in women with
scarred, irregular cavities [50,51].
Surgical curettage was difficult in four of the women
in this case series. Palep-Singh et al [24] reported a preg-
nancy after microwave ablation, after failure of stan-
dard medical management and surgical evacuation.
The patient was then given a single intramuscular dose
(50 mg/m2) of methotrexate. The patient experienced
vaginal bleeding 1 week later and a transvaginal scan
showed no gestational sac 3 weeks after the injection.
Xia et al [22] reported a successful termination of preg-
nancy after hysteroscopic adhesiolysis in a woman with
an obliterated lower uterine segment. They reported
another case in whom 700 mL of heavy arterial bleed-
ing occurred after suction curettage. The bleeding was
controlled by the insertion of a Foley balloon to tam-
pon the cavity [22]. As in Case 1 described above, the
obstructed lower segment made it difficult to pass the
uterine sound, resulting in failed surgical abortion.
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Abnormal placental adherence was found in 16
women, which necessitated hysterectomies in nine (56%)
pregnancies. The most common predisposing factor is
previous uterine surgery, such as cesarean section, myo-
mectomy, curettage or EA. If the invasion is not detected
antenatally, the patient can experience massive hemor-
rhage. Unfortunately, placenta accreta is not easily de-
tected by antenatal ultrasound, as in Case 2 described
above, and as reported by Hamar et al [43] and Patni
et al [45]. Hamar et al hypothesized that the placenta
was adhered to an abnormal uterine lining with limited
focal placental invasion. Therefore, the sonographic
findings may differ from those associated with classic
placenta accreta, which include visualization of irregular
vascular spaces within the placenta (placental lacunae),
bladder–uterine serosa interphase hypervascularity, pro-
minent subplacental venous complexes, and the absence
of an echolucent area between the placenta and myo-
metrium [43]. Patni et al reported a similar case of
placenta increta that a 40-year-old woman, who was
pregnant at 30 weeks of gestation, experienced a pre-
term premature rupture of membranes at 33 weeks of
gestation 4 years after TCRE. The ultrasound examina-
tion revealed an anterior placenta spread over the entire
anterior wall like a thin sheet, and an indistinct utero-
placenta interface [45]. Color Doppler scanning has been
used to detect placenta accreta with a reported sensi-
tivity of 82% and a negative predictive value of 95% to
diagnose placenta accreta [52]. Magnetic resonance
imaging may complement ultrasound in the diagnosis
of placenta accreta, increta, or percreta. Magnetic res-
onance imaging is usually performed during the sec-
ond or third trimester because of theoretical safety
concerns regarding tissue overheating by radiofre-
quency pulses.
There were five congenital anomalies reported in this
series, but only Mukul and Linn [42] reported a case
with fetal malformations and neonatal death caused
by intrauterine synechiae after EA. The male infant had
positional deformities in the neck, an asymmetrical
chest, severe scoliosis, bilateral clubbed feet with extrem-
ity arthrogryposis. An amniotic band constriction was
found on the right leg, causing significant ischemia
and necrosis [42]. Other anomalies such as craniosyn-
ostosis in a term 2,520 g baby [6], a set of twins with
Down syndrome born to a 40-year-old mother [39], a
349 g stillbirth with bilateral talipes [40], and a pre-
term 3,000 g baby with agenesis of the corpus callo-
sum [41] have also been reported. However, these rare
fetal anomalies affecting pregnancies after EA are
probably coincidental.
The current total or global EA procedures cause sig-
nificant intrauterine adhesion and contractures, and
are associated with long-term adverse effects, which
include painful central hematometra, cornual hemato-
metra, and postablation tubal sterilization syndrome
in patients with tubal ligation [53]. Postablation tubal
sterilization syndrome consists of painful hematos-
alinges, resulting from active endometrial tissue near
the cornual region and endometrial scarring and con-
tractures that prevent menstrual egress. A partial roller-
ball ablation procedure in which only one (anterior or
posterior) wall is resected and ablated was proposed
to prevent intrauterine scarring and contractures, and
thus avoid such complications [54,55]. This approach
allows the normal endometrial surface to oppose the
injured exposed myometrial surface, so that adhesions
and contractures do not occur. To date, there has been
only one report of a pregnancy after partial EA. This
pregnancy only proceeded to 28 weeks of gestation,
and does not yet show potential benefits for women
wishing to retain fertility [27].
Since EA has become a popular treatment for men-
orrhagia, more women of reproductive age may have
undergone this procedure with a variety of technolo-
gies. It is essential that contraceptive measures are im-
plemented for all patients after EA, unless the women
reaches menopause or has confirmed tubal obstruc-
tion. A newly developed hysteroscopic tubal occlusion
microinsert device, Essure (Conceptus, San Carlos, CA,
USA), can be used by physicians with experience in oper-
ative hysteroscopy. However, the use of this device con-
comitantly with a microinsert device for hysteroscopic
sterilization during EA is not recommended. Except for
balloon EA, no electrosurgical procedures, microwave,
or radiofrequency EA should be performed after inser-
tion of a hysteroscopic microinsert device [56].
Many pregnancies after EA are incomplete and are
underreported; therefore, an international registry study
to record more case reports is suggested.
In summary, pregnancy after EA is associated with
an increased rate of maternal complications and peri-
natal mortality. Clinicians must recognize the potential
complications and offer appropriate preoperative coun-
seling and postoperative contraception with continued
follow-up.
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